(Q83210605)
Statements
CEA and CA19.9 as early predictors of progression in advanced/metastatic colorectal cancer patients receiving oxaliplatin-based chemotherapy and bevacizumab (English)
Roberto Petrioli
Antonella Licchetta
Giandomenico Roviello
Alessandra Pascucci
Edoardo Francini
Gianluca Bargagli
Raffaele Conca
Salvatora Tindara Miano
Giuseppe Marzocca
Guido Francini
Multidisciplinary Oncology Group On Gastrointestinal Tumors
1 January 2012